Cargando…
Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: A meta-analysis
BACKGROUND: The prognostic value of pretreatment systemic immune-inflammation index (SII) in lung cancer has yet to be fully established. METHODS: Relevant articles were obtained by performing a systematic search. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were used to assess the rel...
Autores principales: | Zhang, Yi, Chen, Bo, Wang, Lijuan, Wang, Rong, Yang, Xianjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370019/ https://www.ncbi.nlm.nih.gov/pubmed/30653090 http://dx.doi.org/10.1097/MD.0000000000013788 |
Ejemplares similares
-
FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma: A meta-analysis
por: Zhang, Yi, et al.
Publicado: (2018) -
ROX INDEX A PROMISING NONINVASIVE INDEX
por: PATIL, SARANG
Publicado: (2021) -
Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis
por: Li, Xing, et al.
Publicado: (2021) -
Systemic immune-inflammation index (SII): A More Promising Inflammation-Based Prognostic Marker for Patients with synchronic colorectal peritoneal carcinomatosis
por: Yan, Qian, et al.
Publicado: (2020) -
Predictive value of the systemic immune-inflammation index for cancer-specific survival of osteosarcoma in children
por: Ouyang, Haiping, et al.
Publicado: (2022)